ABSTRACT
Background Many challenges lie ahead for COVID-19, not only related to the acceleration of the pandemic, but also to the prediction of the hospital’s personal protective equipment to accommodate the explosive demand. Due to the situation of uncertainty, the hospital administration encourages the excess stock of these materials, causing excess products in some hospitals, but shortages in others. Although three main factors limit the number of patients seen at a hospital: the number of beds available, the number of equipment, and, above all, the number of health professionals available at the hospital, per shift.
Objective In this scenario, a challenge is to build an easy-to-use expert system to predict the demand for personal protective equipment in hospitals during the COVID-19 pandemic, with updating in real-time.
Methods We propose naive statistical modeling, which combines historical data on the consumption of personal protective equipment by hospitals, current protocols for their uses and epidemiological data related to the disease, in order to build predictive models for the demand for personal protective equipment in Brazilian hospitals during the pandemic. We then embed our modeling in the free Safety-Stock expert system, that can provide the safety stock for a particular hospital.
Results The Safety-Stock provides prediction of consumption/demand for personal protective equipment over time, indicating the moment when the hospital reaches maximum consumption, the estimate of how long it will work in this state, and when it will leave it.
Conclusion With our predictions, a hospital may have estimated, based on its stock levels and possible new purchases, its needs related to a specific personal protective equipment, which allows for the adoption of strategies to control and keep the stock at safety levels to the demand, mitigating risk of stock-out. As a direct consequence, it enables interchange and cooperation between hospitals, aiming to maximize the care during the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was carried out using the computational resources of the Center for Mathematical Sciences Applied to Industry (CeMEAI), funded by FAPESP (2013/07375-0). Francisco Louzada is supported by the Brazilian agency CNPq (301976/2017-1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There is no IRB/oversight body.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
There is no statement regarding the availability of any data.
